We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$108B
1-Year Est. Return
37.29%
This Fund
S&P 500
This Quarter
Est. Return
+2.03%
1 Year Est. Return
+37.29%
3 Year Est. Return
+69.2%
5 Year Est. Return
+43.82%
10 Year Est. Return
–
AUM
$23.2B
AUM Growth
+$4.57B
(+24%)
Cap. Flow
+$933M
Cap. Flow
% of AUM
4.01%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
3,215
New
812
Increased
777
Reduced
812
Closed
734
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$286M |
| 2 |
Cigna
CI
|
+$183M |
| 3 |
Honeywell
HON
|
+$156M |
| 4 |
ConocoPhillips
COP
|
+$150M |
| 5 |
Abbott
ABT
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$180M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$123M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$116M |
| 4 |
CME Group
CME
|
+$115M |
| 5 |
Texas Instruments
TXN
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.16% |
| 2 | Technology | 13.42% |
| 3 | Consumer Discretionary | 11.26% |
| 4 | Financials | 11.11% |
| 5 | Healthcare | 11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
iShares S&P 500 Growth ETF
IVW
$76.7B
| $628K | ﹤0.01% |
9,823
+6,887
| +235% | +$421K |
|
1477
Rigel Pharmaceuticals
RIGL
$856M
| $625K | ﹤0.01% |
+47,337
| New | +$752K |
|
|
PINE
1478
Alpine Income Property Trust
PINE
$315M
| $623K | ﹤0.01% |
36,998
+23,511
| +174% | +$436K |
|
1479
iShares Global Clean Energy ETF
ICLN
$2.11B
| $621K | ﹤0.01% |
+31,387
| New | +$622K |
|
1480
Cartesian Therapeutics
RNAC
$238M
| $620K | ﹤0.01% |
14,868
+12,633
| +565% | +$594K |
|
1481
Magnachip Semiconductor
MX
$103M
| $619K | ﹤0.01% |
66,742
-54,653
| -45% | -$541K |
|
1482
CubeSmart
CUBE
$9.05B
| $619K | ﹤0.01% |
+13,389
| New | +$601K |
|
1483
NMI Holdings
NMIH
$3.23B
| $617K | ﹤0.01% |
27,651
-23,048
| -45% | -$517K |
|
1484
Invesco Aerospace & Defense ETF
PPA
$7.64B
| $617K | ﹤0.01% |
7,660
-4,837
| -39% | -$386K |
|
1485
ProFrac Holding
ACDC
$922M
| $615K | ﹤0.01% |
48,546
+32,797
| +208% | +$638K |
|
1486
Cohen & Steers
CNS
$3.74B
| $613K | ﹤0.01% |
9,587
+1,652
| +21% | +$115K |
|
1487
Amerant Bancorp
AMTB
$1.16B
| $613K | ﹤0.01% |
28,165
+11,408
| +68% | +$304K |
|
|
STR
1488
DELISTED
Sitio Royalties
STR
| $612K | ﹤0.01% |
+27,090
| New | +$672K |
|
1489
Vanguard International Dividend Appreciation ETF
VIGI
$9.09B
| $610K | ﹤0.01% |
8,276
+3,510
| +74% | +$254K |
|
|
IGD
1490
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$498M
| $610K | ﹤0.01% |
119,542
+1,000
| +0.8% | +$5.3K |
|
1491
Commerce Bancshares
CBSH
$8.24B
| $609K | ﹤0.01% |
12,079
-73,990
| -86% | -$4.13M |
|
1492
Globalstar
GSAT
$10.7B
| $608K | ﹤0.01% |
34,970
+31,451
| +894% | +$580K |
|
|
TEF
1493
DELISTED
Telefonica
TEF
| $607K | ﹤0.01% |
141,806
-542,589
| -79% | -$2.15M |
|
1494
Sonic Automotive
SAH
$2.08B
| $605K | ﹤0.01% |
11,136
+4,457
| +67% | +$240K |
|
1495
Trupanion
TRUP
$1.12B
| $604K | ﹤0.01% |
14,082
-14,571
| -51% | -$788K |
|
|
TERN
1496
DELISTED
Terns Pharmaceuticals
TERN
| $603K | ﹤0.01% |
50,951
+40,406
| +383% | +$386K |
|
1497
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $601K | ﹤0.01% |
+11,728
| New | +$594K |
|
1498
HealthEquity
HQY
$7.82B
| $600K | ﹤0.01% |
+10,215
| New | +$620K |
|
1499
Iovance Biotherapeutics
IOVA
$4.54B
| $599K | ﹤0.01% |
98,031
-87,924
| -47% | -$607K |
|
|
NXDT
1500
NexPoint Diversified Real Estate Trust
NXDT
$281M
| $598K | ﹤0.01% |
+57,617
| New | +$682K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q1 2023 Portfolio in Review
As of Q1 2023, Qube Research & Technologies (QRT) held 3,215 positions worth $23.2B, up 24% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Qube Research & Technologies (QRT) deployed $933M of net new capital in Q1 2023, opening 812 new positions and adding to 777 existing holdings. Its largest new stake was First Republic Bank: 2,786,874 shares worth $39M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $180M trimmed.
- Qube Research & Technologies (QRT)'s largest Q1 2023 buy was First Republic Bank: 2,786,874 shares worth $39M.
- Qube Research & Technologies (QRT) added most to Cigna in Q1 2023, an estimated $183M increase.
- Qube Research & Technologies (QRT)'s biggest Q1 2023 reduction was Apple, cutting an estimated $180M.
- Qube Research & Technologies (QRT) fully exited Vertex Pharmaceuticals in Q1 2023, selling an estimated $123M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 24% of its $23.2B portfolio in Q1 2023.
- Qube Research & Technologies (QRT) opened 812 new positions and closed 734 in Q1 2023.
- Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $23.2B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.